POZ - Latino Hub : Treatment News : New Ideas About Reaching HIV Sanctuaries in the Body

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
|
|
|
|
|
|
|
|
|
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

June 22, 2009

New Ideas About Reaching HIV Sanctuaries in the Body

A joint U.S. and Canadian team of researchers say they have confirmed how specific immune cells serve as a protected reservoir of HIV, despite potent antiretroviral (ARV) therapy. They also offer ideas for eradicating that sanctuary of cells—and the virus along with it—in a study published online June 21 in Nature Medicine.

Scientists once though that HIV might be eradicated in people who kept their viral loads undetectable for several years using ARV therapy. Ultimately, they learned that HIV manages to hide out in some very long-lived cells in lymph nodes throughout the body that remain unaffected by HIV treatment. When ARV therapy is stopped, the virus comes roaring back.

Nicolas Chomont, PhD, from the Université de Montréal, Canada, and his colleagues in Montreal and Florida claim they have now confirmed which cells specifically serve as hidden sanctuaries, and how those cells manage to replicate new virus even when potent ARV therapy is being used.

The cells in question are memory CD4s—cells programmed, often in childhood, at the time of an initial infection with a disease-causing microorganism. This particular group of cells was determined to be the long-lived sanctuary of HIV more than 10 years ago.

Chomont’s team went one step further and believes it has confirmed why memory CD4s aren’t vulnerable to HIV drugs—the cells subdivide, thus replicating not only the cells, but also the virus that has become embedded in the cells’ genetic code. ARV treatment can’t reach that virus because HIV remains in the cells that are actively replicating.

The authors hope that they and other scientists may be able to develop a one-two punch that will include not only ARV therapy, but also drugs that keep the memory CD4 cells from dividing. According to Chomont, if ARV therapy is used long enough, and most of the infected cells die, then there is a chance that the infection may ultimately burn itself out.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Kirk, Dallas, 2009-06-26 10:46:41
This is really encouraging news. I look forward to further discussion.

ED, , 2009-06-24 10:12:36
How can you differentiate between memeory cells specific for HIV and those for other infections. It seems like if you indiscriminately sprevent multiplication of all memory cells you will in the end be predisponsing the patient to all other diseases that they had developed immunity from.

comments 1 - 2 (of 2 total)    


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.